Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ROKU
|
Anthony J. Wood
CEO and Chairman BOD |
BUY
Conversion of derivative security
|
Indirect | 25,000 Added 33.33% |
-
|
Nov 02
2020 |
|
ROKU
|
Anthony J. Wood
CEO and Chairman BOD |
SELL
Bona fide gift
|
Direct | 10,000 Reduced 100.0% |
$27,600
$2.76 p/Share
|
Nov 02
2020 |
|
ROKU
|
Anthony J. Wood
CEO and Chairman BOD |
SELL
Open market or private sale
|
Indirect | 35,000 Reduced 9.05% |
$7,297,850
$208.51 p/Share
|
Nov 02
2020 |
|
ELS
|
Patrick Waite
President & COO |
BUY
Grant, award, or other acquisition
|
Direct | 4 Added 0.0% |
$201
$50.31 p/Share
|
Nov 02
2020 |
|
ELS
|
Tao Huang
Director |
BUY
Grant, award, or other acquisition
|
Direct | 178 Added 0.57% |
$8,955
$50.31 p/Share
|
Nov 02
2020 |
|
XYL
|
Sandra E. Rowland
SVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 4,797 Added 50.0% |
-
|
Nov 02
2020 |
|
SEDG
|
Meir Adest
VP, Core Technologies |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.62% |
$1,342,400
$268.48 p/Share
|
Nov 02
2020 |
|
SEDG
|
Meir Adest
VP, Core Technologies |
BUY
Exercise of conversion of derivative security
|
Direct | 2,393 Added 0.77% |
$41,016
$17.14 p/Share
|
Nov 02
2020 |
|
FDS
|
Daniel Viens
EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 18 Reduced 0.85% |
$5,517
$306.5 p/Share
|
Nov 02
2020 |
|
FDS
|
Frederick Philip Snow
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,769 Reduced 31.23% |
$549,611
$310.69 p/Share
|
Nov 02
2020 |
|
FDS
|
Frederick Philip Snow
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,769 Added 23.8% |
$232,287
$131.31 p/Share
|
Nov 02
2020 |
|
INCY
|
Barry P Flannelly
EVP & General Manager US |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 33.34% |
$1,732,000
$86.6 p/Share
|
Nov 02
2020 |
|
INCY
|
Barry P Flannelly
EVP & General Manager US |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 25.01% |
$968,800
$48.44 p/Share
|
Nov 02
2020 |
|
SWK
|
Donald Allan
President & CEO |
SELL
Open market or private sale
|
Direct | 39,483 Reduced 32.35% |
$6,620,115
$167.67 p/Share
|
Nov 02
2020 |
|
SWK
|
Donald Allan
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 14.08% |
$1,903,600
$95.18 p/Share
|
Nov 02
2020 |
|
SWK
|
Janet Link
SVP, General Counsel & Sec'y |
SELL
Open market or private sale
|
Direct | 1,928 Reduced 9.33% |
$324,907
$168.52 p/Share
|
Nov 02
2020 |
|
HOLX
|
Allison P Bebo
SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct | 16,797 Added 27.1% |
-
|
Nov 02
2020 |
|
HOLX
|
Sean S. Daugherty
Group President, BSH & Surg. |
BUY
Grant, award, or other acquisition
|
Direct | 17,432 Added 35.31% |
-
|
Nov 02
2020 |
|
HOLX
|
John M. Griffin
General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 34,716 Added 21.07% |
-
|
Nov 02
2020 |
|
HOLX
|
Kevin R Thornal
Group Pres, Global Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct | 17,750 Added 33.79% |
-
|
Nov 02
2020 |
|
HOLX
|
Jan Verstreken
Group President, International |
BUY
Grant, award, or other acquisition
|
Direct | 16,797 Added 28.19% |
-
|
Nov 02
2020 |
|
HOLX
|
Karleen Marie Oberton
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 16,941 Added 24.8% |
-
|
Nov 02
2020 |
|
HOLX
|
Stephen P Macmillan
Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 900,307 Added 25.55% |
-
|
Nov 02
2020 |
|
MDB
|
Cedric Pech
President, Field Operations |
SELL
Open market or private sale
|
Indirect | 600 Reduced 0.73% |
$136,200
$227.0 p/Share
|
Nov 02
2020 |
|
MDB
|
Cedric Pech
President, Field Operations |
BUY
Exercise of conversion of derivative security
|
Indirect | 5,729 Added 6.52% |
$48,124
$8.4 p/Share
|
Nov 02
2020 |
|
MDB
|
Dwight A Merriman
Director |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 0.17% |
$676,440
$225.48 p/Share
|
Nov 02
2020 |
|
MDB
|
Dwight A Merriman
Director |
SELL
Open market or private sale
|
Direct | 14,000 Reduced 0.93% |
$3,175,760
$226.84 p/Share
|
Nov 02
2020 |
|
MDB
|
Charles M Hazard Jr
Director |
SELL
Open market or private sale
|
Indirect | 350 Reduced 1.52% |
$79,450
$227.0 p/Share
|
Nov 02
2020 |
|
MDB
|
Charles M Hazard Jr
Director |
SELL
Open market or private sale
|
Direct | 1,666 Reduced 1.88% |
$375,883
$225.62 p/Share
|
Nov 02
2020 |
|
PWR
|
Patrick Wood Iii
Director |
SELL
Bona fide gift
|
Direct | 1,059 Reduced 5.48% |
-
|
Nov 02
2020 |
|
PWR
|
Donald Wayne
EVP and General Counsel |
SELL
Bona fide gift
|
Direct | 1,583 Reduced 2.99% |
-
|
Nov 02
2020 |
|
PWR
|
Donald Wayne
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 11,200 Reduced 17.45% |
$703,808
$62.84 p/Share
|
Nov 02
2020 |
|
PWR
|
James Redgie Probst
Chief Operating Officer |
SELL
Bona fide gift
|
Indirect | 1,620 Reduced 7.49% |
-
|
Nov 02
2020 |
|
PWR
|
James Redgie Probst
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 118,780 Reduced 84.6% |
$7,606,671
$64.04 p/Share
|
Nov 02
2020 |
|
PWR
|
Nicholas M Grindstaff
VP - Finance and Treasurer |
SELL
Open market or private sale
|
Direct | 8,256 Reduced 17.55% |
$532,760
$64.53 p/Share
|
Nov 02
2020 |
|
PWR
|
Jerry K Lemon
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 23.39% |
$257,400
$64.35 p/Share
|
Nov 02
2020 |
|
PWR
|
Earl C. Austin Jr.
President and CEO |
SELL
Open market or private sale
|
Direct | 150,000 Reduced 19.75% |
$9,559,500
$63.73 p/Share
|
Nov 02
2020 |
|
PWR
|
Paul Craig Gregory
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 96,493 Reduced 38.9% |
$6,163,008
$63.87 p/Share
|
Nov 02
2020 |
|
PWR
|
Bernard Fried
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 28.78% |
$643,200
$64.32 p/Share
|
Nov 02
2020 |
|
RJF
|
Bella Loykhter Allaire
Chief Admin Officer |
SELL
Open market or private sale
|
Direct | 3,178 Reduced 5.48% |
$247,598
$77.91 p/Share
|
Nov 02
2020 |
|
ALGN
|
Yuval Shaked
SVP & Mng Dir. Itero |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 30.15% |
$432,100
$432.1 p/Share
|
Nov 02
2020 |
|
FTV
|
Barbara B. Hulit
President & CEO of AHS |
SELL
Open market or private sale
|
Direct | 100,180 Reduced 55.6% |
$6,328,370
$63.17 p/Share
|
Nov 02
2020 |
|
FTV
|
Barbara B. Hulit
President & CEO of AHS |
BUY
Exercise of conversion of derivative security
|
Direct | 100,180 Added 35.73% |
$2,094,764
$20.91 p/Share
|
Nov 02
2020 |
|
TTD
|
Susan Vobejda
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 1,240 Reduced 3.39% |
$708,710
$571.54 p/Share
|
Nov 02
2020 |
|
TTD
|
Susan Vobejda
Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,240 Added 3.36% |
$118,073
$95.22 p/Share
|
Nov 02
2020 |
|
TTD
|
Brian John Stempeck
Director |
BUY
Bona fide gift
|
Indirect | 16,139 Added 50.0% |
-
|
Nov 02
2020 |
|
TTD
|
Brian John Stempeck
Director |
SELL
Bona fide gift
|
Direct | 16,139 Reduced 32.27% |
-
|
Nov 02
2020 |
|
LH
|
Paul R Kirchgraber
CEO, Covance Drug Development |
SELL
Payment of exercise price or tax liability
|
Direct | 895 Reduced 8.87% |
$185,471
$207.23 p/Share
|
Nov 02
2020 |
|
LH
|
Paul R Kirchgraber
CEO, Covance Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct | 2,006 Added 17.9% |
-
|
Nov 02
2020 |
|
LH
|
Adam H Schechter
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 885 Reduced 9.13% |
$183,399
$207.23 p/Share
|
Nov 02
2020 |